A neutralization assay for chikungunya virus infections in a multiplex format

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• Chikungunya virus (CHIKV) causes chikungunya fever, a debilitating illness with persistent arthritis.
• CHIKV, transmitted by Aedes mosquitoes, has expanded its reach due to climate change and adaptation to Aedes albopictus.
• Currently, no effective treatments or licensed vaccines exist for CHIKV infection.

Purpose of the Study:

• To establish a safe and efficient assay for measuring CHIKV neutralizing activity.
• To facilitate the screening of potential entry inhibitors and the development of CHIKV therapeutics and vaccines.
• To enhance the understanding of CHIKV epidemics and antibody responses.

Main Methods:

• Development of a CHIKV neutralization assay using CHIKV-pseudotyped lentiviral vectors in a 384-well format.
• Optimization of lentiviral vector production and reaction volumes for improved safety (S2 level) and efficiency.
• Measurement of dose-dependent, specific neutralization of CHIKV-pseudotyped vectors using sera from CHIKV-infected individuals.

Main Results:

• A CHIKV neutralization assay in a 384-well format was successfully established.
• The assay demonstrated a dose-dependent and specific neutralization of CHIKV-pseudotyped vectors.
• The system allows for screening under a reduced biosafety level (S2).

Conclusions:

• A safe, simple, and multiplex assay for analyzing CHIKV neutralizing activities has been developed.
• This assay will significantly improve drug and vaccine development for CHIKV.
• The assay will also enhance the understanding of CHIKV epidemics and associated antibody responses.